The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparison of HER-2 expression in diagnostic biopsies and surgical specimens of gastric and esophageal adenocarcinoma: Influence of neoadjuvant chemotherapy.
Sarah Watson
No relevant relationships to disclose
Pierre Validire
No relevant relationships to disclose
Pascale Cervera
No relevant relationships to disclose
Nabila Zorkani
No relevant relationships to disclose
Aurelie Scriva
No relevant relationships to disclose
Frederic Lemay
No relevant relationships to disclose
Marie Line Garcia
No relevant relationships to disclose
Mostefa Bennamoun
No relevant relationships to disclose
Christophe Tournigand
No relevant relationships to disclose
Stanislas Ropert
No relevant relationships to disclose
Magali Svrcek
No relevant relationships to disclose
Christophe Louvet
Consultant or Advisory Role - Amgen; Celgene; Pfizer; Roche; Sanofi
Research Funding - Roche